Edwards Lifesciences Corporation Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
Edwards Lifesciences Corporation (EW) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2026-05-06
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2026-03-31 was $0.00.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2025-12-31 was $0.00.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$800.00K.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$1.70M.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2025 was -$4.10M.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2024 was -$4.90M.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2023 was -$3.00M.
- Edwards Lifesciences Corporation income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | -$800.00K derived: sum of 3 quarters · filed 2026-05-06 | -$2.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$800.00K derived: sum of 2 quarters · filed 2026-02-25 | -$2.50M derived: sum of 3 quarters · filed 2026-02-25 | -$4.10M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$800.00K 10-Q · filed 2025-11-05 | -$2.50M derived: sum of 2 quarters · filed 2025-11-05 | -$4.10M 10-Q · filed 2025-11-05 | -$5.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-06-30 | -$1.70M 10-Q · filed 2025-08-06 | -$3.30M 10-Q · filed 2025-08-06 | -$4.60M derived: sum of 3 quarters · filed 2026-05-06 | -$6.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-06 | -$2.90M derived: sum of 2 quarters · filed 2026-05-06 | -$4.30M derived: sum of 3 quarters · filed 2026-05-06 | -$5.60M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.70M derived: sum of 2 quarters · filed 2026-02-25 | -$4.00M derived: sum of 3 quarters · filed 2026-02-25 | -$4.90M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$1.40M 10-Q · filed 2025-11-05 | -$2.70M derived: sum of 2 quarters · filed 2025-11-05 | -$3.60M 10-Q · filed 2025-11-05 | -$3.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$1.30M 10-Q · filed 2025-08-06 | -$2.20M 10-Q · filed 2025-08-06 | -$2.40M derived: sum of 3 quarters · filed 2026-02-25 | -$3.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$900.00K 10-Q · filed 2025-05-06 | -$1.10M derived: sum of 2 quarters · filed 2026-02-25 | -$2.30M derived: sum of 3 quarters · filed 2026-02-25 | -$3.90M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.40M derived: sum of 2 quarters · filed 2026-02-25 | -$3.00M derived: sum of 3 quarters · filed 2026-02-25 | -$3.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.20M 10-Q · filed 2024-11-06 | -$2.80M derived: sum of 2 quarters · filed 2024-11-06 | -$2.80M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | -$1.60M 10-Q · filed 2024-07-31 | -$1.60M 10-Q · filed 2024-07-31 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |